Reaction
Ultrasound Antenatal Screen reporting signals
As of the last recalculation, Ultrasound Antenatal Screen appears in 94 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is NEVIRAPINE (PRR 2,406.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Nevirapine | 48 | 2,406.4 | 2,419.3 |
| Efavirenz | 49 | 2,031.8 | 2,040.8 |
| Ritonavir 100 Mg | 54 | 1,879.6 | 1,886.4 |
| Lopinavir And Ritonavir | 51 | 1,820.1 | 1,827.1 |
| Zidovudine | 49 | 1,693.8 | 1,700.1 |
| Raltegravir | 50 | 1,431.4 | 1,435.7 |
| Labetalol | 44 | 1,373.4 | 1,378.0 |
| Tenofovir Disoproxil Fumarate Tablets | 33 | 1,303.6 | 1,308.6 |
| Ritonavir | 54 | 960.3 | 962.1 |
| Lamivudine Oral | 49 | 894.8 | 896.5 |
| Lamivudine | 50 | 764.4 | 765.6 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 51 | 540.1 | 540.7 |
| Cyanocobalamin | 42 | 509.6 | 510.2 |
| Tenofovir Disoproxil Fumarate | 35 | 373.0 | 373.4 |
| Insulin Aspart | 48 | 327.5 | 327.8 |